首页> 外文OA文献 >Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

【2h】

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

机译：普伐他汀在冠状动脉粥样硬化中的局限性（PLAC I）：减少动脉粥样硬化进展和临床事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Pitt Bertram; Mancini G.B. John; Ellis Stephen G.; Rosman Howard S.; Park Jong-Soon; Mcgovern Mark E.;
展开▼
作者单位

展开▼
年度 1995
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. [J] . Gerstein HC, Ratner RE, Cannon CP, Circulation: An Official Journal of the American Heart Association . 2010,第10期

机译：罗格列酮对2型糖尿病和冠心病患者冠状动脉粥样硬化进展的影响：罗格列酮对糖尿病心血管疾病史患者预防动脉粥样硬化进展的评估。
2. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). [J] . Zhao XQ, Krasuski RA, Baer The American Journal of Cardiology . 2009,第11期

机译：脂质联合疗法对代谢综合征冠状动脉疾病患者冠状动脉狭窄进展和临床心血管事件的影响：家族性动脉粥样硬化治疗研究（FATS），HDL-动脉粥样硬化治疗研究（HATS）和武装力量回归研究的综合分析（AFREGS）。
3. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. [J] . Bertrand OF, Poirier P, Rodes Cabau J The Canadian journal of cardiology . 2009,第9期

机译：一项多中心，随机，双盲安慰剂对照试验，评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理。
4. Atherosclerosis progression in human coronary arteries assessed by ARTreat modeling: pathophysiological insights by a patient-specific approach [C] . 10th IEEE International Conference on Information Technology and Applications in Biomedicine . 2010

机译：通过ARTreat模型评估人冠状动脉的动脉粥样硬化进展：通过患者特定方法进行病理生理学分析
5. Coronary artery calcification and its progression as a marker of asymptomatic coronary atherosclerosis. [D] . Maher, Julie Elizabeth. 1997

机译：冠状动脉钙化及其作为无症状冠状动脉粥样硬化的标志物的进展。
6. Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients with Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS) the HDL-Atherosclerosis Treatment Study (HATS) and the Armed Forces Regression Study (AFREGS) [O] . Xue-Qiao Zhao, Richard A. Krasuski, Jefferson Baer, -1

机译：组合脂质治疗对代谢综合征患者冠状动脉狭窄进展和临床心血管事件的影响：家族动脉粥样硬化治疗（脂肪）HDL-动脉粥样硬化处理研究（帽子）和武装部队回归研究的综合分析（Afregs）
7. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Design features and recruitment statistics of a U.S. multicenter quantitative angiographic trial of lipid-lowering [O] . Pitt Bertram, Ellis Stephen G., Mancini G.B.John, 1991

机译：普伐他汀在冠状动脉粥样硬化中的局限性（PLAC I）：一项美国多中心降血脂定量血管造影试验的设计特征和募集统计

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

著录项

引文网络

相似文献

相关主题

期刊订阅